# A Short Report on Melanocyte/Melanoma Culture, Senescence, and Reproducibility

**Authors:** Lionel Larue, Duarte C. Barral, Veronique Delmas, Sara Egea‐Rodriguez, Daniel Aldea, Heather C. Etchevers, Marie‐Dominique Galibert, Robert N. Kelsh, Luisa Lanfrancone, Michele Madigan, Pedro Moura‐Alves, Richard M. White, Anja Bosserhoff

PMC · DOI: 10.1111/pcmr.70084 · 2026-03-10

## TL;DR

Experts discussed common issues in melanocyte and melanoma cell culture that affect reproducibility and suggested better documentation and shared practices to improve research consistency.

## Contribution

The paper identifies key technical pitfalls and proposes community-driven standards to enhance reproducibility in pigment cell research.

## Key findings

- Low-density seeding and temperature fluctuations significantly alter cell behavior.
- Species-specific differences in melanocyte models strongly influence experimental outcomes.
- Transparent documentation of protocols and conditions is more effective than rigid standardization.

## Abstract

At the 2025 ESPCR (European Society for Pigment Cell Research) meeting in Erlangen, a workshop on “Pigment Cell Models: Sensitivity, Innovation, and the Challenges of Cell Culture” brought together researchers to discuss technical, methodological, and reproducibility issues in culturing melanocytes, keratinocytes, fibroblasts, and melanoma cells. The discussion between experts in the field highlighted key and recurrent pitfalls affecting experimental outcomes, including low‐density seeding, temperature fluctuations, over‐passaging, and mycoplasma contamination, as well as sources of variability arising from media composition, batch effects, and environmental conditions. Importantly, the workshop distinguished between practices supported by evidence and consensus‐based guidance derived from collective expert experience. Species‐ and donor‐specific differences, especially between human, mouse, and zebrafish melanocyte models, were identified as additional major determinants of experimental variability. Emerging systems, including human and mouse pluripotent stem cell (PSC)‐derived melanocytes, as well as avian and zebrafish melanoma lines, were discussed for their complementary mechanistic and translational value. Overall, the workshop concluded that transparent documentation, explicit reporting standards, and shared best practices are essential to improve reproducibility and further advance pigment cell research.

Workshop focus (ESPCR 2025, Erlangen): International experts identified recurrent technical and methodological pitfalls in melanocyte, keratinocyte, fibroblast, and melanoma cell culture that undermine reproducibility.
Major technical vulnerabilities: Low‐density seeding, temperature fluctuations, over‐confluence/over‐passaging, and mycoplasma contamination significantly alter pigmentation, proliferation, metabolism, and differentiation state.
Media and environmental variability: Differences in media formulation, batch effects, proprietary supplements, oxygen tension, pH, CO2, and handling practices introduce substantial inter‐laboratory variability.
Evidence vs. expert consensus: The workshop clearly distinguished experimentally validated practices from consensus‐based guidance derived from collective experience in the pigment cell field.
Species‐ and donor‐specific differences: Human, mouse, and zebrafish melanocyte models differ in telomere biology, senescence mechanisms, microenvironmental context, and differentiation behavior, strongly influencing experimental interpretation.
Emerging complementary models: PSC‐derived melanocytes, zebrafish and avian melanoma lines, and large mammal systems expand mechanistic and translational opportunities but introduce additional standardization challenges.
Planning principle: Experimental design should begin at least two passages prior to assays (“two passages before” principle) to stabilize cultures and improve reproducibility.
Documentation over rigid standardization: Transparent reporting of cell origin, passage history, media composition, environmental conditions, and quality control measures is more impactful than imposing a single universal protocol.
Community‐driven reproducibility: Shared reporting standards, open protocol platforms, and explicit disclosure of variability are essential to strengthen robustness and comparability in pigment cell research.

Workshop focus (ESPCR 2025, Erlangen): International experts identified recurrent technical and methodological pitfalls in melanocyte, keratinocyte, fibroblast, and melanoma cell culture that undermine reproducibility.

Major technical vulnerabilities: Low‐density seeding, temperature fluctuations, over‐confluence/over‐passaging, and mycoplasma contamination significantly alter pigmentation, proliferation, metabolism, and differentiation state.

Media and environmental variability: Differences in media formulation, batch effects, proprietary supplements, oxygen tension, pH, CO2, and handling practices introduce substantial inter‐laboratory variability.

Evidence vs. expert consensus: The workshop clearly distinguished experimentally validated practices from consensus‐based guidance derived from collective experience in the pigment cell field.

Species‐ and donor‐specific differences: Human, mouse, and zebrafish melanocyte models differ in telomere biology, senescence mechanisms, microenvironmental context, and differentiation behavior, strongly influencing experimental interpretation.

Emerging complementary models: PSC‐derived melanocytes, zebrafish and avian melanoma lines, and large mammal systems expand mechanistic and translational opportunities but introduce additional standardization challenges.

Planning principle: Experimental design should begin at least two passages prior to assays (“two passages before” principle) to stabilize cultures and improve reproducibility.

Documentation over rigid standardization: Transparent reporting of cell origin, passage history, media composition, environmental conditions, and quality control measures is more impactful than imposing a single universal protocol.

Community‐driven reproducibility: Shared reporting standards, open protocol platforms, and explicit disclosure of variability are essential to strengthen robustness and comparability in pigment cell research.

Culture phenotype is determined by the balance between variable physiology and implemented stability measures, ensuring robust and reproducible pigmentation, proliferation, metabolism, and differentiation data.

## Linked entities

- **Diseases:** melanoma (MONDO:0005105)
- **Species:** Homo sapiens (taxon 9606), Mus musculus (taxon 10090), Danio rerio (taxon 7955)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, FOXD3 (forkhead box D3) [NCBI Gene 27022] {aka AIS1, Genesis, HFH2, VAMAS2}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, WNT3A (Wnt family member 3A) [NCBI Gene 89780], SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, TERT (telomerase reverse transcriptase) [NCBI Gene 7015] {aka CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1}, EDNRB (endothelin receptor type B) [NCBI Gene 1910] {aka ABCDS, ET-B, ET-BR, ETB, ETB1, ETBR}, MITF (melanocyte inducing transcription factor) [NCBI Gene 4286] {aka CMM8, COMMAD, MI, MITF-A, WS2, WS2A}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, CDK4 (cyclin dependent kinase 4) [NCBI Gene 1019] {aka CMM3, MCPH31, PSK-J3}, POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, KITLG (KIT ligand) [NCBI Gene 4254] {aka DCUA, DFNA69, FPH2, FPHH, KL-1, Kitl}, EDN3 (endothelin 3) [NCBI Gene 1908] {aka ET-3, ET3, HSCR4, PPET3, WS4B}, DCT (dopachrome tautomerase) [NCBI Gene 1638] {aka OCA8, TRP-2, TYRP2}, PAX3 (paired box 3) [NCBI Gene 5077] {aka CDHS, HUP2, PAX-3, WS1, WS3}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, TYR (tyrosinase) [NCBI Gene 7299] {aka ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3}
- **Diseases:** cancer (MESH:D009369), pigmentation (MESH:D010859), vitiligo (MESH:D014820), liver metastasis (MESH:D009362), Melanoma (MESH:D008545), death (MESH:D003643)
- **Chemicals:** 12-O-tetradecanoylphorbol-13-acetate (MESH:D013755), F-12 (MESH:C007782), MCDB153 (MESH:C112696), DMEM (-), Oxygen (MESH:D010100), tryptophan (MESH:D014364), copper (MESH:D003300), cAMP (MESH:D000242), trace element (MESH:D014131), CO  2 (MESH:D002245), CHIR99021 (MESH:C473711), FBS (MESH:C523711)
- **Species:** Fundulus heteroclitus (Atlantic killifish, species) [taxon 8078], Mus musculus (house mouse, species) [taxon 10090], Canis lupus familiaris (dog, subspecies) [taxon 9615], Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955], Sus scrofa (pig, species) [taxon 9823], Pan troglodytes (chimpanzee, species) [taxon 9598], Rubroshorea almon (species) [taxon 292004], Xenopus tropicalis (tropical clawed frog, species) [taxon 8364], Mycoplasma (genus) [taxon 2093], Oryzias latipes (Japanese medaka, species) [taxon 8090], Xenopus laevis (African clawed frog, species) [taxon 8355], Equus caballus (domestic horse, species) [taxon 9796]
- **Mutations:** Q61R, C-28 C, BRAFV600E, C-36 C
- **Cell lines:** RPE — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388), ZCREST1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), ESCs — Mus musculus (Mouse), Embryonic stem cell (CVCL_9108), SK-MEL-28 — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_0526), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), B16-F10 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0159)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12975704/full.md

---
Source: https://tomesphere.com/paper/PMC12975704